Please note that a publication can be assigned to several endpoints, i.e. the sum of publications from the individual thematic points and subpoints can be greater than the total sum of actual publications.
| Authors | Year | Exposed system | Parameters | Magnetic flux density/field strength |
|---|---|---|---|---|
| Gurhan H et al. | 2021 | intact cell/cell culture, HT-1080 (fibrosarcoma cells) | static magnetic field | - |
| Gurhan H et al. | 2023 | intact cell/cell culture, HT-1080 (fibrosarcoma cells) | static magnetic field, magnetic field, intermediate frequency, co-exposure | - |
| Bajtoš M et al. | 2024 | intact cell/cell culture, HT-1080 (fibrosarcoma cells) | static magnetic field, magnetic field, 50/60 Hz, co-exposure | - |
| Castello PR et al. | 2014 | intact cell/cell culture, HT1080 cells (human fibrosarcoma cell line) | RF, magnetic field, static magnetic field, co-exposure | - |
| Gurhan H et al. | 2018 | intact cell/cell culture, HT1080 cells (human fibrosarcoma cell line) | static magnetic field | - |
| Raylman RR et al. | 1996 | intact cell/cell culture, HTB 63 (melanoma cells), HTB 77 IP3 (ovarian carcinoma cells) and CCL 86 (lymphoma cells) | static magnetic field | 7 T |
| Comfort KK et al. | 2013 | intact cell/cell culture, HaCaT cells (human keratinocytes cell line) | static magnetic field, co-exposure, also other exposures without EMF | - |
| Hiraoka M et al. | 1992 | intact cell/cell culture, HeLa S3 (human cervical carcinoma cell line) | static magnetic field | 0.18–0.2 T |
| Sato K et al. | 1992 | intact cell/cell culture, HeLa S3 (human cervical carcinoma cell line) | static magnetic field | 0.2 T |
| Wang Z et al. | 2014 | intact cell/cell culture, HeLa cell line (human adenocarcinoma cell line) and MCF-7 (human breast cancer cell line) | static magnetic field, DC | 0.26–0.33 T |
This website uses cookies to provide you the best browsing experience. By continuing to use this website you accept our use of cookies.
